COVID-associated complications after reconstructive breast surgery: a retrospective cohort study

J. M. Bubberman, J. J. M. Claessen1, Michelle Marlena Wilhelmina Feijen2, Marleen A.J. Meesters-Caberg2, Sander M J van Kuijk3, René R. W. J. van der Hulst4, Stefania Tuinder4
1Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
2Department of Plastic, Reconstructive and Hand Surgery, Zuyderland Medical Center, Sittard-Geleen, The Netherlands
3Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center, Maastricht, the Netherlands
4GROW – School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands

Tóm tắt

Abstract Purpose

The COVID pandemic significantly influenced reconstructive breast surgery regimens. Many surgeries were cancelled or postponed. COVID entails not only respiratory, but also coagulative symptoms. It, therefore, potentially increases the risk of postoperative complications. The incidence of perioperative COVID infection and its influence on postoperative recovery after reconstructive breast surgery is still unknown.

Methods

This dual center retrospective cohort study included patients that underwent reconstructive breast surgery between March 2020 and July 2021. Post-mastectomy autologous or implant-based breast reconstruction (ABR; IBR), as well as post-lumpectomy oncoplastic partial breast reconstruction (PBR) were eligible. Patient data were extracted from electronic medical records. Data regarding COVID-19 infection was collected through a questionnaire. The primary outcome was complication rate.

Results

The ABR, IBR and PBR groups consisted of 113 (12 COVID-positive), 41 (2 COVID-positive) and 113 (10 COVID-positive) patients. In the ABR and PBR groups, postoperative complications occurred significantly more often in patients with perioperative COVID-infection. Especially impaired wound healing occurred significantly more often in the ABR and PBR breasts, but also at the donor site of ABR patients with perioperative COVID.

Conclusion

Perioperative COVID-infection increases susceptibility to complicated wound healing after reconstructive breast surgery. A possible explanation lies in the dysregulation of haemostasis by the virus, and its direct effects on microvasculature. A hypercoagulable state results. We recommend to postpone elective breast surgery for 4–6 weeks after COVID-19 infection. Also, precautionary measures remain important to minimize the risk of perioperative COVID-19 infection.

Từ khóa


Tài liệu tham khảo

Cordeiro PG (2008) Breast reconstruction after surgery for breast cancer. N Engl J Med 359(15):1590–1601

Lisa A, Battistini A, Giannasi S, Veronesi A, Bandi V, Maione L et al (2020) Breast reconstruction in a coronavirus disease 2019 hub. Plast Reconstr Surg Glob Open 8(7):e3043

Salgarello M, Adesi LB, Visconti G, Pagliara DM, Mangialardi ML (2020) Considerations for performing immediate breast reconstruction during the COVID-19 pandemic. Breast J 26(7):1485–1487

Vidya R, Rubio IT, Paulinelli RR, Rancati A, Kolacinska-Voytkuv A, Salgarello M et al (2020) Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic? Ecancermedicalscience 14:1041

COVIDSurg Collaborative (2020) Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 396(10243):27–38

Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z et al (2020) Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter Study during the COVID-19 outbreak. Cancer Discov 10(6):783–791

Liang W, Guan W, Chen R, Wang W, Li J, Xu K et al (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337

Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R et al (2020) Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan. China Ann Oncol 31(7):894–901

Jallali N, Hunter JE, Henry FP, Wood SH, Hogben K, Almufti R et al (2020) The feasibility and safety of immediate breast reconstruction in the COVID-19 era. J Plast Reconstr Aesthet Surg 73(11):1917–1923

Patel NG, Reissis D, Mair M, Hart A, Ragbir M, Giele H et al (2021) Safety of major reconstructive surgery during the peak of the COVID-19 pandemic in the United Kingdom and Ireland - multicentre national cohort study. J Plast Reconstr Aesthet Surg 74(6):1161–1172

COVIDSurg Collaborative, (2020) Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg 107(11):1440–1449

Bunch CM, Moore EE, Moore HB, Neal MD, Thomas AV, Zackariya N et al (2022) Immuno-thrombotic complications of COVID-19: implications for timing of surgery and anticoagulation. Front Surg 9:889999

Collaborative C (2022) Mortality and pulmonary complications in emergency general surgery patients with COVID-19: a large international multicenter study. J Trauma Acute Care Surg 93(1):59–65

Deng JZ, Chan JS, Potter AL, Chen YW, Sandhu HS, Panda N et al (2022) The risk of postoperative complications after major elective surgery in active or resolved COVID-19 in the United States. Ann Surg 275(2):242–246

Forlenza EM, Higgins JDD, Burnett RA, Serino J, Della Valle CJ (2022) COVID-19 infection after total joint arthroplasty is associated with increased complications. J Arthroplasty 37(7S):S457–S464

Meyer CH, Grant A, Sola R, Gills K, Mora AN, Tracy BM et al (2022) Presentation, clinical course and complications in trauma patients with concomitant COVID-19 infection. Am J Surg 224:607–11

Neumaier M, Thirukumaran C, Ramirez G, Ricciardi B (2022) Heightened 30-Day Postoperative Complication Risk Persists After COVID-19 Infection. World J Surg.1–10.

Prasad NK, Mayorga-Carlin M, Sahoo S, Englum BR, Turner DJ, Siddiqui T et al (2022) Mid-term surgery outcomes in patients with COVID-19: results from a nationwide analysis. Ann Surg 224:920–928

American Society of Anesthesiologists APSF. ASA and ASPF joint statement on elective surgery and anesthesia for patients after COVID-19 Infection 2021. Available from: https://www.asahq.org/about-asa/newsroom/news-releases/2021/03/asa-and-apsf-jointstatement-on-elective-surgery-and-anesthesia-for-patients-after-covid-19-infection-rv. Accessed October 25, 2022

COVIDSurg Collaborative, Collaborative G, (2021) Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia 76(6):748–758

El-Boghdadly K, Cook TM, Goodacre T, Kua J, Denmark S, McNally S et al (2022) Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update: A multidisciplinary consensus statement on behalf of the Association of Anaesthetists, Centre for Perioperative Care, Federation of Surgical Specialty Associations, Royal College of Anaesthetists, Royal College of Surgeons of England. Anaesthesia 77(5):580–587

Recuenco CB, Cano Pecharroman EM, Mendoza Esparrell GM, Ramos ME, Benitez JB, Martin Paniagua L, et al. (2022) [Evolutionary analysis of patient s morbidity and mortality in emergency surgical care during the pandemic: retrospective comparison between the first and second waves of COVID-19.]. Cir Esp.

Prasad NK, Lake R, Englum BR, Turner DJ, Siddiqui T, Mayorga-Carlin M et al (2022) COVID-19 Vaccination Associated With Reduced Postoperative SARS-CoV-2 Infection and Morbidity. Ann Surg 275(1):31–36

Chiariello GA, Bruno P, Pavone N, Calabrese M, D’Avino S, Ferraro F et al (2022) Bleeding Complications in Patients With Perioperative COVID-19 Infection Undergoing Cardiac Surgery: A Single-Center Matched Case-Control Study. J Cardiothorac Vasc Anesth 36(7):1919–1926

Silveira L, Guerreiro GP, Lisboa LAF, Mejia OAV, Dallan LRP, Dallan LAO et al (2020) Coronary Artery Bypass Graft During the COVID-19 Pandemic. Braz J Cardiovasc Surg 35(6):1003–1006

Kielbowski K, Wojtys M, Kostopanagiotou K, Janowski H, Wojcik J (2022) Association of major postoperative wound and anastomotic complications in thoracic surgery with COVID-19 infection. Surg Open Sci 10:208–215

Cardiothoracic Interdisciplinary Research Network, Collaborative C (2021) Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study. J Thorac Cardiovasc Surg 162(2):e355–e372

Sharma R, Chaudhary D, Goel P, Khandelwal S, Singh V, Kapoor R (2021) COVID-19 Masquerading as Postoperative Surgical Complications after Cancer Surgery. Indian J Surg Oncol 12(Suppl 2):290–293

Vrba R, Lubuska L, Spicka P (2022) Hybrid transthoracic oesophagectomy due to carcinoma with complications after COVID-19 pneumonia - A case report. Int J Surg Case Rep 90:106749

Inouye D, Zhou S, Clark B, Swanson M, Chambers T (2021) Two Cases of Impaired Wound Healing Among Patients With Major Head and Neck Free-Flap Reconstruction in the Setting of COVID-19 Infection. Cureus 13(12):e20088

Chen J, Chow A, Lee E, Wesson T, Karius A, Wallam S, et al. (2022) Reintroducing Flap Reconstruction: One Institution's Safe Return to Flap Surgery during the COVID-19 Pandemic. J Reconstr Microsurg.

Talmor G, Grube JG, Eloy JA, Liu JK, Hsueh WD (2020) Nasoseptal Flap Necrosis After Endoscopic Skull Base Surgery in the Setting of COVID-19 Pandemic. World Neurosurg 140:374–377

Benmoussa N, de Kerangal Q, Leymarie N, Breuskin I, Rigal T, Alkhashnam H et al (2020) Failure of Free Flaps in Head and Neck Oncology Surgery in COVID-19 Patients. Plast Reconstr Surg 146(2):251e-e252

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417–1418

Weiss E, Roux O, Moyer JD, Paugam-Burtz C, Boudaoud L, Ajzenberg N et al (2020) Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy. Thromb Haemost 120(9):1343–1345

Wright FL, Vogler TO, Moore EE, Moore HB, Wohlauer MV, Urban S, et al. (2020) Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection. J Am Coll Surg. 231(2):193–203 e1.

Wool GD, Miller JL (2021) The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology 88(1):15–27

Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y et al (2020) SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol 13(1):120